# Orient EuroPharma Co., Ltd. (4120.TWO): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Orient EuroPharma Co., Ltd. (4120.TWO) is 44/100, ranked against 24,000+ stocks in 35 markets (Quality 32, Value 48, Momentum 56, each scored against its sector).

- StockRank: 44/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 32, Value 48, Momentum 56: each a 0-100 percentile within the stock's sector.
- Position: #15,063 overall, #1,313 in Healthcare.
- Listing: Taiwan, TWO; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 45.55 TWD on 13 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/4120.TWO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker